Literature DB >> 19429418

Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver.

Ansar A Khan1, Edwin C Y Chow, Anne-miek M A van Loenen-Weemaes, Robert J Porte, K Sandy Pang, Geny M M Groothuis.   

Abstract

In this study, we compared the regulation of CYP3A isozymes by the vitamin D receptor (VDR) ligand 1 alpha,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) against ligands of the pregnane X receptor (PXR), the glucocorticoid receptor (GR) and the farnesoid X receptor (FXR) in precision-cut tissue slices of the rat jejunum, ileum, colon and liver, and human ileum and liver. In the rat, 1,25(OH)(2)D(3) strongly induced CYP3A1 mRNA, quantified by qRT-PCR, along the entire length of the intestine, induced CYP3A2 only in ileum but had no effect on CYP3A9. In contrast, the PXR/GR ligand, dexamethasone (DEX), the PXR ligand, pregnenolone-16 alpha carbonitrile (PCN), and the FXR ligand, chenodeoxycholic acid (CDCA), but not the GR ligand, budesonide (BUD), induced CYP3A1 only in the ileum, none of them influenced CYP3A2 expression, and PCN, DEX and BUD but not CDCA induced CYP3A9 in jejunum, ileum and colon. In rat liver, CYP3A1, CYP3A2 and CYP3A9 mRNA expression was unaffected by 1,25(OH)(2)D(3), whereas CDCA decreased the mRNA of all CYP3A isozymes; PCN induced CYP3A1 and CYP3A9, BUD induced CYP3A9, and DEX induced all three CYP3A isozymes. In human ileum and liver, 1,25(OH)(2)D(3) and DEX induced CYP3A4 expression, whereas CDCA induced CYP3A4 expression in liver only. In conclusion, the regulation of rat CYP3A isozymes by VDR, PXR, FXR and GR ligands differed for different segments of the rat and human intestine and liver, and the changes did not parallel expression levels of the nuclear receptors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429418     DOI: 10.1016/j.ejps.2009.01.006

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  26 in total

1.  Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies.

Authors:  Inge A M de Graaf; Peter Olinga; Marina H de Jager; Marjolijn T Merema; Ruben de Kanter; Esther G van de Kerkhof; Geny M M Groothuis
Journal:  Nat Protoc       Date:  2010-08-19       Impact factor: 13.491

2.  Vitamin D receptor activation induces P-glycoprotein and increases brain efflux of quinidine: an intracerebral microdialysis study in conscious rats.

Authors:  Matthew R Durk; Jianghong Fan; Huadong Sun; Yingbo Yang; Henrianna Pang; K Sandy Pang; Inés A M de Lannoy
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

3.  A mechanism-based pharmacokinetic/pharmacodynamic model for CYP3A1/2 induction by dexamethasone in rats.

Authors:  Liang Li; Zai-quan Li; Chen-hui Deng; Miao-ran Ning; Han-qing Li; Shan-shan Bi; Tian-yan Zhou; Wei Lu
Journal:  Acta Pharmacol Sin       Date:  2012-01       Impact factor: 6.150

Review 4.  FXR signaling in the enterohepatic system.

Authors:  Tsutomu Matsubara; Fei Li; Frank J Gonzalez
Journal:  Mol Cell Endocrinol       Date:  2012-05-17       Impact factor: 4.102

5.  Glucocorticoid exposure induces preeclampsia via dampening 1,25-dihydroxyvitamin D3.

Authors:  Dongxin Zhang; Ji Zeng; Xili Miao; Haojing Liu; Liangfang Ge; Wei Huang; Jinyu Jiao; Duyun Ye
Journal:  Hypertens Res       Date:  2017-11-02       Impact factor: 3.872

6.  Intestinal CYP3A4 and midazolam disposition in vivo associate with VDR polymorphisms and show seasonal variation.

Authors:  Ranjit K Thirumaran; Jatinder K Lamba; Richard B Kim; Brad L Urquhart; Jamie C Gregor; Nilesh Chande; Yiping Fan; An Qi; Cheng Cheng; Kenneth E Thummel; Stephen D Hall; Erin G Schuetz
Journal:  Biochem Pharmacol       Date:  2012-03-30       Impact factor: 5.858

Review 7.  Vitamin D deficiency in chronic liver disease.

Authors:  Paula Iruzubieta; Álvaro Terán; Javier Crespo; Emilio Fábrega
Journal:  World J Hepatol       Date:  2014-12-27

8.  1α,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells.

Authors:  Matthew R Durk; Gary N Y Chan; Christopher R Campos; John C Peart; Edwin C Y Chow; Eason Lee; Ronald E Cannon; Reina Bendayan; David S Miller; K Sandy Pang
Journal:  J Neurochem       Date:  2012-11-01       Impact factor: 5.372

9.  Vitamin D Enhances the Efficacy of Irinotecan through miR-627-Mediated Inhibition of Intratumoral Drug Metabolism.

Authors:  Meiyan Sun; Qunshu Zhang; Xiaoyu Yang; Steven Y Qian; Bin Guo
Journal:  Mol Cancer Ther       Date:  2016-07-25       Impact factor: 6.261

Review 10.  Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective.

Authors:  Bret D Wallace; Matthew R Redinbo
Journal:  Drug Metab Rev       Date:  2012-12-05       Impact factor: 4.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.